Severe Insulin Resistance Syndromes: Clinical Spectrum and Management

Area of Science:

• Endocrinology
• Metabolic Disorders
• Genetics

Background:

• Insulin resistance is a common condition linked to type 2 diabetes, obesity, and metabolic syndrome.
• It involves cellular unresponsiveness to insulin, leading to metabolic disturbances like hyperglycemia and dyslipidemia.
• Severe insulin resistance syndromes represent a rare, heterogeneous group of disorders with profound metabolic abnormalities.

Purpose of the Study:

• To review current knowledge on the epidemiology, pathophysiology, complications, and prognosis of severe insulin resistance syndromes.
• To categorize these syndromes based on underlying disease processes.
• To provide a comprehensive overview for researchers and clinicians.

Main Methods:

• Literature review of existing studies on severe insulin resistance syndromes.
• Synthesis of data on epidemiology, pathophysiology, and clinical manifestations.
• Categorization of syndromes based on etiological factors, including defects in insulin receptor, signaling pathways, and adipose tissue function.

Main Results:

• Severe insulin resistance syndromes are characterized by profound insulin resistance and significant metabolic derangements.
• These syndromes can be hereditary or acquired, stemming from defects in insulin action or adipose tissue function.
• They are associated with a high risk of severe complications and mortality.

Conclusions:

• Severe insulin resistance syndromes encompass a spectrum of rare genetic and acquired disorders.
• Understanding their diverse etiologies, including insulin receptor defects, signaling pathway abnormalities, and lipodystrophies, is crucial for management.
• Further research is needed to improve the prognosis and reduce mortality associated with these complex conditions.